ArticleEMBO reports2016

From HDACi to KDACi: we need to revisit non-epigenetic pathways affected by inhibiting lysine deacetylases in therapy.

Axel Imhof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.